MARC Record from marc_columbia

LEADER: 07073cam a2200781Mi 4500
001 15128918
005 20220604234309.0
006 m o d
007 cr |||||||||||
008 180120s2018 xx o 000 0 eng d
035 $a(OCoLC)on1020032199
035 $a(NNC)15128918
040 $aEBLCP$beng$epn$cEBLCP$dN$T$dNLE$dCRCPR$dOCLCF$dMERER$dOCLCQ$dOTZ$dTYFRS$dOCLCQ$dK6U$dOCLCO
019 $a1019680848$a1021141400
020 $a1351086030$q(electronic bk.)
020 $a9781351086035$q(electronic bk.)
020 $a9781351077583$q(electronic bk.)
020 $a1351077589$q(electronic bk.)
020 $a9781351094481
020 $a1351094483
020 $z9781351086035
020 $z1351077589
020 $z9781315898483
020 $a9781351102933
020 $a1351102931
024 7 $a10.1201/9781351077583$2doi
035 $a(OCoLC)1020032199$z(OCoLC)1019680848$z(OCoLC)1021141400
037 $a9781351094481$bIngram Content Group
050 4 $aRC627.S36$bC53 2018
072 7 $aHEA$x039000$2bisacsh
072 7 $aMED$x014000$2bisacsh
072 7 $aMED$x022000$2bisacsh
072 7 $aMED$x112000$2bisacsh
072 7 $aMED$x045000$2bisacsh
082 04 $a616.3/9$223
049 $aZCUA
100 1 $aClemetson, Alan B.
245 10 $aVitamin C :$bVolume III.
260 $aMilton :$bCRC Press,$c2018.
300 $a1 online resource (279 pages)
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
588 0 $aPrint version record.
505 0 $aCover; Title Page; Copyright Page; FOREWORD; PREFACE; THE AUTHOR; Table of Contents; CHEMICAL CHANGES ASSOCIATED WITH VITAMIN C DEFICIENCY; Chapter 1: Histamine Metabolism; I. Introduction; II. Guinea Pigs; III. Humans; A. Pregnancy; B. Age; C. Sex; D. Subsequent Work; IV. Implications; References; Chapter 2: Proline and Lysine Metabolism; References; Chapter 3: Carbohydrate Metabolism; References; Chapter 4: Folic Acid Metabolism; References; Chapter 5: Cholesterol Metabolism; I. Guinea Pig Studies; II. Other Animals; III. Human Studies; IV. Summary; V. Conclusions; References.
505 8 $aChapter 6: Tyrosine and Phenylalanine MetabolismI. Introduction; II. Hydroxyphenyluria; III. Dopa, Dopamine, Norepinephrine, and Epinephrine; IV. Tyrosine Oxidation to Dopa and Melanin; V. Tyrosine Iodination and Conversion to Thyroxine; VI. Conclusions Concerning Clinical Relevance; References; Chapter 7: Tryptophan Metabolism; References; Chapter 8: Adrenal Corticoid Metabolism; I. Introduction; II. Human Observations; III. Guinea Pigs; IV. Rats; V. In Vitro Studies; References; Chapter 9: Uric Acid Clearance; References.
505 8 $aCLINICAL CONDITIONS ASSOCIATED WITH DISORDERS OF ASCORBIC ACID METABOLISMChapter 10: Rheumatic Fever; I. Experimental Production in the Guinea Pig; A. Controls; B. Infection; C. Scurvy; D. Combined Scurvy and Infection; E. Scurvy and Exotoxin; II. Rheumatic Purpura; III. Epidemiology of Rheumatic Fever; IV. Ascorbate Status in Rheumatic Fever; A. Urinary Excretion Tests; B. Blood Values; V. Ascorbic Acid Supplements in Rheumatic Fever; VI. Use of Ascorbic Acid in Prophylaxis Against Rheumatic Fever; VII. Other Prophylactic and Therapeutic Measures; VIII. The Hyperimmune Response.
505 8 $aIX. The Effect of Cortisone on Ascorbic Acid Metabolism in Rheumatic FeverX. Conclusions; XI. Future Research; References; Chapter 11: Menorrhagia; References; Chapter 12: Wound Dehiscence; References; Chapter 13: Habitual Abortion; References; Chapter 14: Abruptio Placentae; References; Chapter 15: Prematurity and Premature Rupture of the Fetal Membranes; References; Chapter 16: Megaloblastic Anemia of Infancy, Pregnancy, and Steatorrhea; I. Introduction; II. Infancy; Ill. Pregnancy; IV. Steatorrhea, Malabsorption Syndrome; References; Chapter 17: Gastrointestinal Ulcers and Hemorrhage.
505 8 $aI. Human ObservationsII. Studies of Monkeys; III. Guinea Pig Studies; IV. Rat Studies; V. Dog Studies; VI. Observations in Cows and Sheep; VII. Discussion; References; Chapter 18: Ocular Lesions; I. Classical Scurvy; II. Experimental Human Scurvy; III. Hypovitaminosis C in Monkeys and Guinea Pigs; IV. Normal Ascorbate Levels; V. Value of Ascorbic Acid and Bioflavonoids in Various Eye Diseases; A. Hemorrhagic Lesions; B. Eye Infections; C. Wounds of the Eye; D. Corneal Bums; E. Alkali Bums; F. Corneal Ulcers; G. Cataracts; H. Glaucoma; I. Toxic Retinopathy; J. Retinal Detachment.
500 $aK. Osteogenesis Imperfecta.
520 2 $a"The factors affecting blood vitamin C levels are described in detail in this series. Many factors such as aging, smoking, infection, trauma, surgery, hemolysis, hormone administration, heavy metals, pregnancy, alcohol, ionizing radiation and several medicines have been found to cause a disturbance of ascorbic acid metabolism and to reduce blood vitamin C levels. Indeed, abnormalities of ascorbic acid metabolism, due to factors such as smoking, occur much more frequently than does dietary vitamin C deficiency today. It is now known that low blood vitamin C levels are associated with histaminemia (high blood histamine levels), and also that ascorbate-responsive histaminemia is common in apparently healthy people. High blood histamine levels are believed to cause small hemorrhages within the inner walls of the blood vessels and these may lead to the deposition of cholesterol, as an aberrant form of wound healing. Ascorbic acid not only reduces blood histamine levels, but also aids the conversion of cholesterol to bile acids in the liver. The clinical pathological and chemical changes observed in ascorbic acid deficiency are discussed in detail. Several diseases and disorders associated with low blood vitamin C levels are also described. Possible toxic effects resulting from the oxidation of ascorbic acid are noted, and reasons for the use of D-catechin or other chelating fiber to prevent or minimize the release of ascorbate-free radical are detailed. An excellent reference for physicians, nutritionists and other scientists"--Provided by publisher.
504 $aIncludes bibliographical references and index.
650 0 $aVitamin C deficiency.
650 0 $aVitamin C$xMetabolism.
650 2 $aAscorbic Acid Deficiency
650 6 $aAvitaminose C.
650 7 $aHEALTH & FITNESS$xDiseases$xGeneral.$2bisacsh
650 7 $aMEDICAL$xClinical Medicine.$2bisacsh
650 7 $aMEDICAL$xDiseases.$2bisacsh
650 7 $aMEDICAL$xEvidence-Based Medicine.$2bisacsh
650 7 $aMEDICAL$xInternal Medicine.$2bisacsh
650 7 $aVitamin C deficiency.$2fast$0(OCoLC)fst01168204
650 7 $aVitamin C$xMetabolism.$2fast$0(OCoLC)fst01168198
655 0 $aElectronic books.
655 4 $aElectronic books.
776 08 $iPrint version:$aClemetson, Alan B.$tVitamin C : Volume III.$dMilton : CRC Press, ©2018$z9781315898483
856 40 $uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio15128918$zTaylor & Francis eBooks
852 8 $blweb$hEBOOKS